Merck names Robert Davis new CFO
This article was originally published in Scrip
Merck & Co has named Robert M Davis executive vice-president and chief financial officer – effective 23 April 2014. Mr Davis will succeed Peter N Kellogg, who has been CFO at the company since 2007. Mr Kellogg will depart from the company on 16 May 2014. To ensure a smooth transition, he will oversee the closing and reporting of the company's first quarter sales and earnings on 29 April 2014.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.